A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
UNCERTAINTY ASSESSMENT OF THE BLOOD DAMAGE IN A FDA BLOOD PUMP
2019
Proceedings of the 3rd International Conference on Uncertainty Quantification in Computational Sciences and Engineering (UNCECOMP 2019)
unpublished
Heart failure (HF) is a severe cardiovascular disease, millions people are suffered from HF worldwide. The ventricular assist device (VAD) can replace the function of failing hearts, when there are no heart donations available, it is becoming a common daily practice for the heart failure patients. U.S. Food and Drug Administration (FDA) Critical Path Initiative (CPI) announced a benchmark study of a centrifugal blood pump few years ago in order to improve current practices of applying
doi:10.7712/120219.6366.18426
fatcat:ojzer2j7evdstpryv2pcrbfofe